Active Ingredients
(in each tablet)
Fexofenadine HCl 60 mg
(in each tablet)
Pseudoephedrine HCl 120 mg
The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Allegra-d (NDC 50090-1203). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredients, purpose, uses, do not use, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding,, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
(in each tablet)
Fexofenadine HCl 60 mg
(in each tablet)
Pseudoephedrine HCl 120 mg
Antihistamine
Nasal decongestant
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years of age and over | take 1 tablet with a glass of water every 12 hours on an empty stomach; do not take more than 2 tablet in 24 hours |
| children under 12 years of age | do not use |
| adults 65 years of age and older | ask a doctor |
| consumers with kidney disease | ask a doctor |
carnauba wax, colloidal silicon dioxide, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, pregelatinized starch, stearic acid
call toll-free 1-800-633-1610 or www.allegra.com
Product: 50090-1203
NDC: 50090-1203-0 10 TABLET, FILM COATED, EXTENDED RELEASE in a BLISTER PACK
* Please review the disclaimer below.